MIRM
Mirum Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$100.90
+0.27%Margins
Gross margin
81.7%
EBITDA margin
-125.7%
EBIT margin
-17.4%
Net margin
-139.2%
FCF margin
-74.1%
8253.8%
Return on equity
-82.3%
Return on assets
-14.4%
Return on invested capital
0.64x
Asset turnover
-$456.0M
Cash from operations
$6.75
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026